ES2347174T3 - Utilizacion de un derivado benzoilo 3-aminocarbazol para el tratamiento de un trastorno asociado a la produccion de la prostaglandina e2 (pge2). - Google Patents

Utilizacion de un derivado benzoilo 3-aminocarbazol para el tratamiento de un trastorno asociado a la produccion de la prostaglandina e2 (pge2). Download PDF

Info

Publication number
ES2347174T3
ES2347174T3 ES06753538T ES06753538T ES2347174T3 ES 2347174 T3 ES2347174 T3 ES 2347174T3 ES 06753538 T ES06753538 T ES 06753538T ES 06753538 T ES06753538 T ES 06753538T ES 2347174 T3 ES2347174 T3 ES 2347174T3
Authority
ES
Spain
Prior art keywords
production
pge2
group
aminocarbazole
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06753538T
Other languages
English (en)
Spanish (es)
Inventor
Lorenzo Polenzani
Giorgina Mangano
Isabella Coletta
Maria Alessandra Alisi
Nicola Cazzolla
Guido Furlotti
Caterina Maugeri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of ES2347174T3 publication Critical patent/ES2347174T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ES06753538T 2005-05-19 2006-05-03 Utilizacion de un derivado benzoilo 3-aminocarbazol para el tratamiento de un trastorno asociado a la produccion de la prostaglandina e2 (pge2). Expired - Lifetime ES2347174T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI05A0909 2005-05-19
IT000909A ITMI20050909A1 (it) 2005-05-19 2005-05-19 Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-

Publications (1)

Publication Number Publication Date
ES2347174T3 true ES2347174T3 (es) 2010-10-26

Family

ID=35219704

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06753538T Expired - Lifetime ES2347174T3 (es) 2005-05-19 2006-05-03 Utilizacion de un derivado benzoilo 3-aminocarbazol para el tratamiento de un trastorno asociado a la produccion de la prostaglandina e2 (pge2).

Country Status (23)

Country Link
US (1) US8686021B2 (https=)
EP (1) EP1881826B1 (https=)
JP (1) JP5086991B2 (https=)
KR (1) KR101312579B1 (https=)
CN (1) CN101166528B (https=)
AR (1) AR054126A1 (https=)
AT (1) ATE473739T1 (https=)
AU (1) AU2006246688B2 (https=)
BR (1) BRPI0609718A2 (https=)
CA (1) CA2604562C (https=)
DE (1) DE602006015457D1 (https=)
DK (1) DK1881826T3 (https=)
EA (1) EA012724B1 (https=)
ES (1) ES2347174T3 (https=)
GE (1) GEP20094738B (https=)
IL (1) IL186072A (https=)
IT (1) ITMI20050909A1 (https=)
MX (1) MX2007013491A (https=)
PL (1) PL1881826T3 (https=)
PT (1) PT1881826E (https=)
SI (1) SI1881826T1 (https=)
UA (1) UA94044C2 (https=)
WO (1) WO2006122680A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20051523A1 (it) 2005-08-03 2007-02-04 Acraf Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
EP2119705A1 (en) 2008-05-14 2009-11-18 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor
US8792839B2 (en) 2009-05-14 2014-07-29 Qualcomm Incorporated Allocating transmit power among multiple air interfaces

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
WO2001007409A1 (en) 1999-07-23 2001-02-01 Astrazeneca Uk Limited Carbazole derivatives and their use as neuropeptide y5 receptor ligands
US6399631B1 (en) 1999-07-23 2002-06-04 Pfizer Inc. Carbazole neuropeptide Y5 antagonists
CA2381111A1 (en) * 1999-08-26 2001-03-01 Leah M. Giupponi Npy antagonists: spiroisoquinolinone derivatives
DE10125961A1 (de) * 2001-05-29 2002-12-12 Boehringer Ingelheim Int Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden
CA2403307A1 (en) * 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
KR20030042344A (ko) * 2001-11-22 2003-05-28 한국생명공학연구원 에레모필란계 화합물 또는 곰취추출물을 유효성분으로함유하는 염증질환 치료제, 면역질환 치료제, 및 암 치료제
ES2193875B2 (es) * 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
KR100402714B1 (ko) * 2002-12-23 2003-11-13 한국생명공학연구원 디테르펜계 화합물을 염증질환, 면역질환 및 암 치료제로사용하는 신규한 용도

Also Published As

Publication number Publication date
EA200702534A1 (ru) 2008-04-28
AU2006246688B2 (en) 2011-09-22
UA94044C2 (ru) 2011-04-11
AU2006246688A1 (en) 2006-11-23
BRPI0609718A2 (pt) 2011-10-18
KR101312579B1 (ko) 2013-09-30
MX2007013491A (es) 2008-01-24
US20080287518A1 (en) 2008-11-20
KR20080018898A (ko) 2008-02-28
EA012724B1 (ru) 2009-12-30
SI1881826T1 (sl) 2010-10-29
CA2604562C (en) 2013-09-17
PL1881826T3 (pl) 2010-12-31
ATE473739T1 (de) 2010-07-15
EP1881826B1 (en) 2010-07-14
ITMI20050909A1 (it) 2006-11-20
CN101166528A (zh) 2008-04-23
DE602006015457D1 (de) 2010-08-26
CN101166528B (zh) 2011-06-15
IL186072A0 (en) 2008-08-07
PT1881826E (pt) 2010-08-05
DK1881826T3 (da) 2010-11-01
CA2604562A1 (en) 2006-11-23
JP5086991B2 (ja) 2012-11-28
IL186072A (en) 2012-05-31
HK1119571A1 (en) 2009-03-13
AR054126A1 (es) 2007-06-06
JP2008540591A (ja) 2008-11-20
GEP20094738B (en) 2009-07-27
WO2006122680A1 (en) 2006-11-23
EP1881826A1 (en) 2008-01-30
US8686021B2 (en) 2014-04-01

Similar Documents

Publication Publication Date Title
ES2428226T3 (es) Compuesto de 3-aminocarbazol, composición farmacéutica que lo contiene y procedimiento para su preparación
CN103249408A (zh) 利用多不饱和长链酮类的类风湿性关节炎治疗
IL187713A (en) 3-aminocarbazole compounds, pharmaceutical preparations containing them and methods for their preparation
CN1331683A (zh) 2－苯基苯并咪唑化合物和2－苯基吲哚化合物,它们的制备和用途
BRPI0806608A2 (pt) métodos para prevenir ou reduzir o número de surtos agudos de gota utilizando inibidores xantina oxidoredutase e agentes anti-inflamatórios
HUP0001286A2 (hu) Karbazol-ecetsavat tartalmazó, kutyák fájdalmának és gyulladásának kezelésére alkalmas gyógyszerkészítmény
CN101506161A (zh) 具有快速皮肤穿透速度的带正电荷的水溶性的芳基和杂芳基丙酸类前药
PT1303265E (pt) ''utilização de inibidores da cox-2 como imuno-estimulantes, no tratamento do vih ou da sida''
US20050042282A1 (en) Methods using proton pump inhibitors
CN101506160A (zh) 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药
ES2347174T3 (es) Utilizacion de un derivado benzoilo 3-aminocarbazol para el tratamiento de un trastorno asociado a la produccion de la prostaglandina e2 (pge2).
WO2006016689A1 (ja) Ｅｐ４アゴニストを含有してなる下部尿路系疾患の予防および／または治療剤
WO2004089411A1 (ja) 脊柱管狭窄症治療剤
TW200406405A (en) Selective inhibitors of cyclooxygenase-2
Krowicki Involvement of hindbrain and peripheral prostanoids in gastric motor and cardiovascular responses to delta-9-tetrahydrocannabinol in the rat
RU2336872C2 (ru) Аннелированные пиррольные соединения как ингибиторы протонового насоса для лечения язвы
HK1119571B (en) Use of a benzoyl derivative of 3-aminocarbazole in manufacture of a medicament in the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
JP2005508830A (ja) ピリジン誘導体を用いる方法
Raju et al. Cyclooxygenase inhibitors
Chetty Raju et al. Cyclooxygenase inhibitors
HINZª et al. 13 Antipyretic analgesics
JP2010006731A (ja) 腫瘍治療薬
CN103772259A (zh) 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药